Advertisement
Advertisement
BDSX
Biodesix, Inc. Common Stock
15.32
USDSponsored
-0.15
-0.97%
May 08, 16:00 UTC -4
Closed
After-Market
15.18
-0.14
-0.91%
BDSX Earnings Reports
Positive Surprise Ratio
BDSX beat 15 of 23 last estimates.
65%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$26.70M
/-$0.86
Implied change from Q1 26 (Revenue/ EPS)
+4.46%
/+6.17%
Implied change from Q2 25 (Revenue/ EPS)
+33.38%
/-46.25%
Biodesix, Inc. Common Stock earnings per share and revenue
On May 04, 2026, BDSX reported earnings of -0.81 USD per share (EPS) for Q1 26, beating the estimate of -1.11 USD, resulting in a 27.54% surprise. Revenue reached 25.56 million, compared to an expected 23.64 million, with a 8.11% difference. The market reacted with a +32.56% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.86 USD, with revenue projected to reach 26.70 million USD, implying an increase of 6.17% EPS, and increase of 4.46% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
FAQ
What were Biodesix, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Biodesix, Inc. Common Stock reported EPS of -$0.81, beating estimates by 27.54%, and revenue of $25.56M, 8.11% above expectations.
How did the market react to Biodesix, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 32.56%, changed from $11.27 before the earnings release to $14.94 the day after.
When is Biodesix, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Biodesix, Inc. Common Stock's next earnings report?
Based on 5
analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$0.86 and revenue of $26.70M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement